120 related articles for article (PubMed ID: 36549099)
1. Geometrical analysis identified morphological features of hydrogel-induced cancer stem cells in synovial sarcoma model cells.
Ferdous Z; Clément JE; Gong JP; Tanaka S; Komatsuzaki T; Tsuda M
Biochem Biophys Res Commun; 2023 Jan; 642():41-49. PubMed ID: 36549099
[TBL] [Abstract][Full Text] [Related]
2. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells in sarcomas: Getting to the stemness core.
Skoda J; Veselska R
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2134-2139. PubMed ID: 30003939
[TBL] [Abstract][Full Text] [Related]
4. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
Zayed H; Petersen I
Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
[TBL] [Abstract][Full Text] [Related]
6. SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling.
Qi Y; Dong SS; He YL; Liu ZH; Huang YL; Wang N; Zhang Z; Li Z; Shi METHTM; Feng X; Yao Q; Zou H; Hu JM; Pang LJ; Li F
BMC Cancer; 2022 Feb; 22(1):166. PubMed ID: 35151264
[TBL] [Abstract][Full Text] [Related]
7.
Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
[TBL] [Abstract][Full Text] [Related]
8. Synovial sarcoma is a stem cell malignancy.
Naka N; Takenaka S; Araki N; Miwa T; Hashimoto N; Yoshioka K; Joyama S; Hamada K; Tsukamoto Y; Tomita Y; Ueda T; Yoshikawa H; Itoh K
Stem Cells; 2010 Jul; 28(7):1119-31. PubMed ID: 20518020
[TBL] [Abstract][Full Text] [Related]
9. Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels.
Suzuka J; Tsuda M; Wang L; Kohsaka S; Kishida K; Semba S; Sugino H; Aburatani S; Frauenlob M; Kurokawa T; Kojima S; Ueno T; Ohmiya Y; Mano H; Yasuda K; Gong JP; Tanaka S
Nat Biomed Eng; 2021 Aug; 5(8):914-925. PubMed ID: 33782572
[TBL] [Abstract][Full Text] [Related]
10. Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells.
Kimura T; Wang L; Tabu K; Tsuda M; Tanino M; Maekawa A; Nishihara H; Hiraga H; Taga T; Oda Y; Tanaka S
Oncogene; 2016 Jul; 35(30):3932-43. PubMed ID: 26640147
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD133 in synovial sarcoma.
Terry J; Nielsen T
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):159-65. PubMed ID: 19752721
[TBL] [Abstract][Full Text] [Related]
12. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
13. Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.
Martinez-Cruzado L; Tornin J; Santos L; Rodriguez A; García-Castro J; Morís F; Rodriguez R
Sci Rep; 2016 Jun; 6():27878. PubMed ID: 27292183
[TBL] [Abstract][Full Text] [Related]
14. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
16. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
Tan S; Yamashita A; Gao SJ; Kurisawa M
Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
[TBL] [Abstract][Full Text] [Related]
18. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
[TBL] [Abstract][Full Text] [Related]
19. A Preliminary Study of miR-144 Inhibiting the Stemness of Colon Cancer Stem Cells by Targeting Krüppel-Like Factor 4.
Qiu Z; Tu L; Hu X; Zhou Z; Lin Y; Ye L; Cui C
J Biomed Nanotechnol; 2020 Jul; 16(7):1102-1109. PubMed ID: 33308377
[TBL] [Abstract][Full Text] [Related]
20. SOX2-high cancer cells exhibit an aggressive phenotype, with increases in stemness, proliferation and invasion, as well as higher metabolic activity and ATP production.
Mauro-Lizcano M; Sotgia F; Lisanti MP
Aging (Albany NY); 2022 Dec; 14(24):9877-9889. PubMed ID: 36566021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
